animals, accompanied by reduction in mitochondrial oxidative stress and AIF release. This was accompanied by an elevation in glutathione S-transferase mRNA levels and activity, which suggests that an efficient clearance of the reactive intermediate may contribute to the protection against APAP hepatotoxicity in these mice. These results demonstrate that while HCV infection could exacerbate APAP-induced liver injury due to induction and amplification of mitochondrial oxidant stress, it could also protect against injury by activation of APAP scavenging mechanisms.
Introduction
Acetaminophen (APAP) is one of the most common drugs used worldwide and is safe at therapeutic doses. APAP metabolism generates a reactive intermediate, N-acetyl-pquinone imine (NAPQI), which is effectively scavenged by the glutathione system in the liver after therapeutic doses of the drug. However, it is well recognized that an overdose of APAP can result in severe liver injury in both experimental animals and man (Larson 2007; McGill et al. 2012 ). The injury process after an overdose is initiated by generation of large amounts of NAPQI, which overwhelm the scavenging capability of glutathione (Mitchell et al. 1973) . NAPQI generation results in the subsequent formation of NAPQI-protein adducts, especially on mitochondrial proteins, which has been shown to be a critical feature of APAP-induced hepatotoxicity (Nelson 1990; . Mitochondrial protein adduct formation triggers a cascade of events, including mitochondrial oxidant stress (Jaeschke 1990; Knight et al. Abstract Chronic hepatitis C virus (HCV) infection predisposes patients to develop liver failure after acetaminophen (APAP) overdose. Mechanisms involved in this were explored using transgenic mice expressing the HCV structural proteins core, E1 and E2. Treatment of C57BL/6J mice with 200 mg/kg body weight APAP resulted in significant liver injury at 6 h as indicated by elevated ALT levels, focal centrilobular necrosis and nuclear DNA fragmentation. HCV transgenic mice showed a variable response, with approximately half the animals showing exacerbation of all parameters of liver injury, while the other half was protected. HCV transgenic mice with higher liver injury had lower liver glutathione levels, elevated mitochondrial oxidative stress and enhanced release of apoptosis-inducing factor (AIF) from the mitochondria. This was accompanied by induction of a higher ER stress response and induction of autophagy. Transgenic animals showing protection against liver injury had a robust recovery of liver glutathione content at 6 h when compared to wild-type 1 3
2001) and activation of the c-jun N-terminal kinase (JNK) (Hanawa et al. 2008) , which further amplify the mitochondrial oxidant stress (Saito et al. 2010a) , resulting in induction of the mitochondrial permeability transition (MPT) pore opening (Kon et al. 2004; Masubuchi et al. 2005; Reid et al. 2005; Ramachandran et al. 2011a ). This in turn facilitates the release of mitochondrial intermembrane proteins such as apoptosis-inducing factor (AIF) and endonuclease G, which translocate to the nucleus and induce DNA fragmentation, resulting in the subsequent hepatocyte necrosis (Bajt et al. 2006 (Bajt et al. , 2008 (Bajt et al. , 2011 . Thus, mitochondrial dysfunction is central to the pathophysiology of APAP-induced cell death in animals ) and humans .
Acetaminophen overdose is the leading cause of liver failure in the Western world (Larson et al. 2005) , and recent epidemiological studies examining predisposition to APAPinduced liver failure in humans demonstrate that patients with hepatitis C virus (HCV) infection have a significant predisposition to develop liver failure after APAP overdose (Nguyen et al. 2008) . HCV is a hepatotropic pathogen of significant importance to public health, chronically infecting an estimated 130 million people worldwide (Ploss and Rice 2009) . Chronic HCV infection leads to the development of cirrhosis and hepatocellular carcinoma, making HCV infection one of the most common causes of liver transplantation (Brown 2005) . Understanding the molecular basis for the increased susceptibility of HCV-infected patients to APAP overdose thus has significant clinical importance.
HCV infection has been shown to have significant consequences on organelle function in the hepatocyte. Transgenic mice expressing HCV proteins have been shown to have impaired function of the mitochondrial respiratory chain, resulting in overproduction of ROS, and also compromised antioxidant systems (Moriya et al. 2001; Okuda et al. 2002; Chang et al. 2008) . In addition, the HCV core protein has been shown to localize to the endoplasmic reticulum (ER) and induce ER stress in cells (Benali-Furet et al. 2005; Wang and Weinman 2006) , and transgenic mice expressing the HCV structural proteins core, E1 and E2 demonstrate impair mitochondrial respiratory function (Korenaga et al. 2005) . In light of the fact that mitochondrial function is compromised after HCV infection and is a critical determinant of APAPinduced hepatocyte injury, we explored the role of this organelle in amplifying APAP-induced injury in HCV transgenic mice expressing the HCV structural proteins in the liver.
Materials and methods

Animals
The SL-139 strain of HCV structural protein-expressing mice, which are on a C57Bl/6 background, along with control C57Bl/6 mice, was used in this study (Korenaga et al. 2005) . Since HCV infection is usually chronic, older mice (18 ± 2.5 weeks, mean ± SEM) were used for these studies. All animals were housed in an environmentally controlled room with 12-h light/dark cycle and allowed free access to food and water. The experimental protocol was approved by the Institutional Animal Care and Use Committees of the University of Kansas Medical Center and followed the criteria of the National Research Council for the care and use of laboratory animals in research. All chemicals were purchased from Sigma Chemical Co. (St. Louis, MO, USA) unless stated otherwise.
Experimental design
Mice were injected intraperitoneally with 200 mg/kg APAP (dissolved in warm saline) after overnight fasting. The animals were killed 20 min or 6 h after APAP treatment, and blood was withdrawn from the vena cava into a heparinized syringe for measurement of alanine aminotransferase (ALT) activities (Kinetic Test Kit 68-B, Biotron Diagnostics, Inc., Hemet, CA, USA). The liver was removed and was rinsed in saline; liver sections were fixed in 10 % phosphate-buffered formalin for histological analyses. A portion of the liver was used for mitochondrial isolation, and the remaining liver was snap-frozen in liquid nitrogen and stored at −80 °C.
Histology and immunohistochemistry
Formalin-fixed tissue samples were embedded in paraffin, and 4-μm sections were cut. Replicate sections were stained with hematoxylin and eosin (H&E) for evaluation of necrosis (Gujral et al. 2002) . For the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay, sections of liver were stained with the In Situ Cell Death Detection Kit, AP (Roche Diagnostics, Indianapolis, IN) as described in the manufacturer's instructions (Gujral et al. 2002) .
Measurement of GSH and glutathione S-transferase activity
Total soluble GSH was measured in the liver homogenate with a modified method of Tietze as described in detail (Knight et al. 2001) . Briefly, the frozen tissue was homogenized at 0 °C in 3 % sulfosalicylic acid containing 0.1 mM EDTA. The samples were assayed using dithionitrobenzoic acid. All data are expressed in GSH equivalents. Glutathione S-transferase activity was measured by the increase in absorbance at 340 nm on conjugation of 1-chloro-2,4-dinitrobenzene (CDNB) with reduced glutathione as described (Habig et al. 1974 ).
Isolation of subcellular fractions and Western blotting
Mitochondria and cytosolic fractions were isolated as described (Cover et al. 2005) . Briefly, the liver was homogenized in ice-cold isolation buffer (pH 7.4) containing 220 mM mannitol, 70 mM sucrose, 2.5 mM HEPES, 10 mM EDTA, 1 mM EGTA and 0.1 % bovine serum albumin. Mitochondria were isolated by differential centrifugation (20,000 xg) and washed with 2 ml of isolation buffer. The 20,000 xg supernatant was used to evaluate the release of mitochondrial factors such as apoptosis-inducing factor (AIF) by Western blotting. Western blotting was carried out as described in detail (Bajt et al. 2000) using the following antibodies: a rabbit anti-AIF antibody (Abcam, Cambridge, MA), a rabbit anti-Cyp2E1 polyclonal antibody (Abcam, Cambridge, MA), a mouse anti-Bcl-xl monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA), a rabbit anti-LC-3 polyclonal antibody (MBL, Naka-ku Nagoya, Japan), a mouse anti-GADD 153/CHOP monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA), a rat anti-Grp 78 monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA) and a mouse monoclonal antimetallothionein antibody (DAKO Corp., Carpinteria, CA). A horseradish peroxidase-coupled anti-rabbit IgG (Santa Cruz) was used as secondary antibody. Proteins were visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech Inc., Piscataway, NJ).
Redox Western blotting for thioredoxin-2
For detection of oxidized and reduced forms of thioredoxin 2, mitochondria were resuspended in 20 mM Tris, pH 8.0, and 50 µg of the mitochondrial fraction was incubated with AMS (4-acetamido-4-maleimidylstilbene-2,2-disulfonic acid, Molecular Probes, Grand Island, NY) at a final concentration of 15 mM for 3 h and subsequently analyzed by 16 % SDS-PAGE and Western blot using an anti-thioredoxin 2 antibody (Abcam).
RNA analysis
Mouse Stress and Toxicity PathwayFinder (Cat. no. PAMM-003E-4) PCR array was purchased from SA Biosciences (Qiagen) and was used according to the manufacturer's instructions. For real-time PCR analysis, expression of B cell lymphoma-extra large (Bcl-xl) and GST m3 mRNA was quantified using qRT-PCR analysis as previously described (Williams et al. 2010 ) using the following primers-BCL-XL Fwd: GCTGGGACACTTTTGTGGAT, Rev: TGTCTGGTCACTTCCGACTG; GST-mu-3 Fwd: CACC CGCATACAGCTCATGAT, Rev: TTCTCAGGGATGGC CTTCAA. Briefly, total RNA was reverse transcribed with M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA) and oligo-dT primers (ABI Primer Express software, Foster City, CA). The SYBR green PCR Master Mix (Applied Biosystems, Foster City, CA) was used for real-time PCR analysis. The relative differences in expression between groups were expressed using cycle time (Ct) values. Ct values for the gene were first normalized with that of β-actin in the same sample, and then, relative differences between groups were expressed as relative increases setting control as 1.
Statistics
The Shapiro-Wilk test was used to assess normality. For normally distributed data, one-way analysis of variance (ANOVA) was performed to test for significance, with Student-Newman-Keuls post hoc comparison between groups. For non-normally distributed data, ANOVA was performed on ranks, followed by Dunn's multiple comparisons. For all tests, P < 0.05 was considered significant.
Results
HCV core protein expression and APAP-induced liver injury
To evaluate the potential role of hepatocellular HCV protein expression on APAP hepatotoxicity, a moderate overdose of 200 mg/kg was selected. APAP induced significant liver injury at 6 h as indicated by the increase in plasma ALT activities in wild-type mice (Fig. 1a) . Interestingly, however, HCV protein-expressing mice showed a wide range of ALT activities. Some of the values are clearly below WT levels and some are substantially above (Fig. 1a) . If the ALT value of each individual HCV core protein-expressing animal was plotted against their hepatic GSH level, the animals separated into two distinct groups (Fig. 1b) . The difference to untreated controls and APAP WT animals is also obvious (Fig. 1c, d ). The results from the ALT activities were confirmed by both histology (Fig. 2a) and TUNEL staining (Fig. 2b) , which showed significantly lower cell necrosis and DNA fragmentation in HCV protein-expressing animals that had lower plasma ALT activities. In contrast, animals showing exacerbated injury had much higher cell necrosis and DNA fragmentation than wild-type animals ( Fig. 2 a, b) .
HCV protein expression and APAP metabolic activation
A recent study suggested that down-regulation of cytochrome P450 activity, especially Cyp2e1, by viral infection could result in modulation of APAP toxicity (Getachew et al. 2010 ). However, cytochrome P450 protein levels were similar in both HCV transgenic mice which were protected as well as those which showed aggravated damage (Fig. 3a) . Liver glutathione levels were also similarly depleted in all HCV transgenic animals tested 20 min after APAP treatment (Fig. 3b) , confirming that changes in metabolism of APAP were not contributing to these effects. These effects could also not be explained by alterations in levels of HCV core protein being expressed within liver mitochondria (data not shown).
Mitochondrial oxidant stress and dysfunction in HCV core protein-expressing mice Further experiments were then carried out to elucidate potential mechanisms behind the aggravated injury as well as protection against APAP hepatotoxicity in HCV transgenic animals. Measurement of liver glutathione levels 6 h after APAP administration indicated that in wild-type animals GSH levels had completely recovered (Fig. 4a) . However, in HCV transgenic mice with aggravated injury, GSH levels were significantly lower than both APAP-treated wild-type and untreated control animals (Fig. 4a) . Mitochondrial oxidative stress has been implicated in APAP-induced hepatotoxicity, and thioredoxin-2 (Trx-2) is a mitochondrial antioxidant enzyme whose oxidation is an indication of mitochondrial oxidative stress (Zhang et al. 2007 ). Redox Western blotting of Trx-2 showed that APAP treatment resulted in a significant decrease in the ratio of reduced-to-oxidized protein indicative of mitochondrial oxidative stress in wild-type and HCV transgenic mice with higher injury (Fig. 4b) . In contrast, the protected HCV transgenic mice showed a drastically enhanced reduced-to-oxidized ratio of Trx-2 (Fig. 4b) . APAP-induced mitochondrial oxidative stress induces translocation of apoptosis-inducing factor (AIF) from the mitochondria to the nucleus and subsequent DNA fragmentation and cell necrosis (Bajt et al. 2006 (Bajt et al. , 2011 . Treatment of wild-type animals with APAP resulted in AIF release from mitochondria into the cytosol (Fig. 4c) . However, this was further enhanced in HCV transgenic mice with higher injury and prevented in the protected animals (Fig. 4c) .
To evaluate changes in gene expression which could result in modulation of the response to APAP, a PCR array was initially carried out to examine mRNA levels of 84 genes in the samples. Paradoxically, HCV transgenic mice that had aggravation of injury showed elevated mRNA levels of Bcl-x L (Fig. 5a) , an anti-apoptotic member of the Bcl-2 family. This increase was confirmed by Western blotting of mitochondrial proteins from these animals (Fig. 5a ). In contrast, in the protected animals, Bcl-x L mRNA and protein induction were prevented (Fig. 5a) . Cells overexpressing Bcl-x L and subjected to ER stress die by necrosis subsequent to induction of autophagy (Ullman et al. 2008) . Thus, ER stress and autophagy were investigated in HCV transgenic mice. Treatment of wild-type mice with APAP resulted in an up-regulation of the ER stress marker GADD153/CHOP (Fig. 5b) . However, this was significantly more elevated in HCV transgenic mice which showed exacerbated liver injury and attenuated in animals that were protected (Fig. 5B ). This increase in GADD153/CHOP protein was accompanied by a decrease in Grp78 levels, again to a much greater extent in the HCV transgenic mice with higher injury when compared to wild-type animals (Fig. 6A) . Again, the loss of Grp-78 was prevented in the HCV transgenic mice (Fig. 6a) . Further experiments were then carried out to evaluate the role Fig. 2 Representative liver sections stained with H&E (a) and the TUNEL assay (b) in wild-type controls and HCV transgenic mice 6 h after treatment with APAP (200 mg/kg). HCV transgenic mice with exacerbated injury (HCV + E) or protection (HCV + P) are indicated of autophagy in the aggravated response to APAP in HCV transgenic mice. Conversion of the microtubule-associated protein 1A/1B-light chain 3 (LC3) I to II has been used as a marker of autophagy in general (Tanida et al. 2008 ) and for enhanced autophagy after APAP overdose (Ni et al. 2012a) . A significant increase in the ratio of LC3 II/I was seen in wild-type animals exposed to APAP compared with controls (Fig. 6b) ; HCV transgenic mice with higher injury showed a much pronounced elevation in the ratio indicative of higher induction of autophagy or suppression of LC3II degradation in lysosomes.
The data so far indicate that in HCV transgenic mice with aggravated injury compared with wild-type animals, there is an increased Bcl-x L expression in mitochondria, higher induction of the ER stress response and enhanced autophagy. In contrast, in the animals that showed protection, there was increased recovery of hepatic GSH levels (Fig. 4a ) not only compared to HCV core protein-overexpressing animals with higher injury but also compared to APAP-treated wild-type animals. In addition, there was a more reduced-to-oxidized ratio for mitochondrial Trx-2 (Fig. 4b) , less mitochondrial AIF release (Fig. 4C) , less mitochondrial Bcl-x L expression (Fig. 5a ), less induction of the ER stress gene GADD153/Chop (Fig. 5b ) and reduced loss of Grp78 (Fig. 6a) . However, the ratio of LC II/I in HCV transgenic mice protected against injury was similar to that seen in wild-type mice (Fig. 6b) .
We have earlier demonstrated that metallothionein induction can influence APAP hepatotoxicity presumably by scavenging NAPQI after GSH is exhausted (Saito et al. 2010b ). To determine whether this could play a role in protection against APAP hepatotoxicity, metallothionein protein levels were measured. APAP treatment resulted in an increase in metallothionein levels in wild-type animals as well as HCV transgenic mice, though levels were not as high as in the wild-type animals (Fig. 7a) . The PCR array for 84 genes carried out to elucidate global alterations in protein expression induced by APAP in the HCV transgenic mice also indicated that HCV transgenic animals that were protected against APAP hepatotoxicity showed an elevation of mRNA for glutathione S-transferase (GST) mu-3 (Fig. 7b) . This elevation in gene expression had a functional effect, where activity of GST was significantly elevated in the HCV transgenic animals when compared to wild-type animals and controls (Fig. 7c) .
Discussion
Effect of HCV core protein on APAP hepatotoxicity
The hypothesis that HCV core protein-overexpressing mice would be more susceptible to APAP-induced hepatotoxicity was rather straightforward based on the earlier data showing mitochondrial dysfunction in HCV transgenic mice (Korenaga et al. 2005) , the critical role of mitochondria in APAPinduced liver injury ) and epidemiological data indicating increased susceptibility of HCV-infected humans to APAP-induced liver failure (Nguyen et al. 2008 ). However, the data from the initial experiments in transgenic mice were rather intriguing, since a significant variation in response to APAP-induced liver damage was evident among the animals. In this scenario, it could be argued that these variations could be due to the animal-to-animal variation seen during experimentation, and the average response (namely no effect) would be the best interpretation. Consistent with this conclusion, a recently published study conducted in parallel with ours observed no difference in liver injury between wild-type and HCV transgenic mice 24 h after oral doses of 300-500 mg/kg APAP in fed animals (Uehara et al. 2013 ). However, when using the same dose as we did (200 mg/kg), a moderate aggravation of injury was observed in fasted animals (Uehara et al. 2013) . Since the authors also observed an increased mitochondrial stress, even in animals without enhanced injury, it appears that the dose or use of fed versus fasted mice may not explain the different results. However, the fact that our mice were slightly older, i.e., longer exposed to the chronic stress of the HCV core protein-mediated mitochondrial dysfunction, may have contributed to the increased susceptibility and adaptation. As we have recently demonstrated using conditional Atg5-deficient animals, which have impaired autophagy, animals exposed to chronic stress can be completely resistant to APAP-induced liver injury (Ni et al. 2012b ). Likewise, conditional Atg7-deficient mice do not show any stress during the first few weeks but still respond to APAP with apoptotic cell death rather than necrosis (Igusa et al. 2012; Jaeschke and Ding 2012) . In addition, chronic oxidant stress in thioredoxin reductase 1-deficient animals or in lpr mice triggered adaptation mechanisms that reduced the susceptibility to APAP hepatotoxicity (Patterson et al. 2013; Williams et al. 2013) . Thus, it is feasible that the chronic, low-level mitochondrial stress of HCV core protein overexpression leads to adaptive responses, which make animals more resistant to the subsequent insults, i.e., APAP overdose. The fact that not all animals show this adaptation would indicate that this mild stress does not trigger a uniform response in all mice.
Unfortunately, the nature of the response (protection versus aggravation of injury) is only obvious after challenging the animals, which makes it impossible to predict which animals fall into which category. As a result, we were unable to find a difference in untreated animals that could explain the subsequent response. Even a PCR array looking at 84 different genes revealed only a few minor differences. More experiments are necessary to elucidate these differences.
Metabolic activation of APAP in HCV transgenic animals A major concern with any modulation of APAP-induced liver injury is the question whether there is a difference in metabolic activation. In particular, a recent study demonstrated a 90 % down-regulation of Cyp2e1 protein, the dominant Cyp responsible for NAPQI formation in mice (Lee et al. 1996) , in animals that were infected with a replication-deficient adenovirus to produce acute viral hepatitis. These virus-infected animals were highly resistant to APAP toxicity (Getachew et al. 2010 ). However, there was no significant difference in Cyp2e1 protein expression between our experimental groups. In addition, the depletion of hepatic GSH levels during the first 20 min after APAP overdose, generally considered an indirect but sensitive parameter for NAPQI formation in vivo (Jaeschke 1990; Jaeschke et al., 2011) , which correlates with protein adducts , did not show any significant difference between the groups. Thus, it is highly unlikely that a difference in metabolic activation can explain the difference in the injury response in HCV transgenic mice.
Mitochondrial dysfunction in HCV transgenic animals APAP overdose causes mitochondrial oxidant stress as reflected by increased GSSG levels (Jaeschke 1990 ), MitoSox Red staining (Yan et al. 2010) , increased susceptibility of MnSOD-deficient mice (Fujimoto et al. 2009; Ramachandran et al. 2011b) , selective nitrotyrosine adduct formation in mitochondria (Cover et al. 2005 ) and inactivation of MnSOD by nitration (Agarwal et al. 2011) . In addition, the shift to the more oxidized form of mitochondrial Trx-2, as shown in the current study, further supports this hypothesis. Indirect evidence for mitochondrial dysfunction is provided by the release of intermembrane proteins such as endonuclease G and AIF (Bajt et al. 2006 (Bajt et al. , 2011 , which trigger nuclear DNA fragmentation as documented by the TUNEL assay and other parameters of DNA damage (Bajt et al. 2006 (Bajt et al. , 2011 . AIF is initially released through a Bax pore and later, after the MPT, due to matrix swelling and rupture of the outer membrane (Bajt et al. 2008) . It is also well documented that mitochondrial dysfunction triggers autophagy to remove the damaged organelles and impair the propagation of cell death signaling (Ni et al. 2012a) . The current findings support these concepts. Trx-2 Fig. 7 a Quantitation of metallothionein protein in liver from wildtype and HCV transgenic mice 6 h after APAP (200 mg/kg), with a representative western blot (insert). Values are mean ± SE of ≥3 mice per group. *P < 0.05 (compared to control), # P < 0.05 (compared to APAP WT). b Quantitation of GST mu3 mRNA levels in liver from wild-type and HCV transgenic mice 6 h after APAP (200 mg/kg). Values are mean ± SE of at least three mice per group. c Glutathione S-transferase activity in liver homogenates from wildtype and HCV transgenic mice 6 h after APAP. Values are mean ± SE of ≥3 mice per group. *P < 0.05 (compared to APAP control) oxidation indicates a mitochondrial oxidant stress, AIF release and TUNEL-positive cells indicate mitochondrial dysfunction and DNA damage, increase in LC3II compared with LC3I reflects an increase in autophagy, and the induction of Bcl-x L suggests a response to limit Bax pore formation. In addition, the induction of GADD153/CHOP and reduction of GRP78 confirm an ER stress during APAP overdose (Nagy et al. 2007; Uzi et al. 2013) . It has been shown that the modulation of almost all of these events or processes can affect APAP-induced cell death. Not surprising, the mitochondrial oxidant stress (Trx-2) and dysfunction (AIF release, DNA damage), and the evidence of ER stress (GADD153/CHOP induction, Grp78 decline) were exacerbated in the more susceptible HCV transgenic animals and attenuated in the resistant mice. Along with the higher injury, the recovery of hepatic GSH levels was delayed compared with the resistant animals. However, Bcl-x L and MT protein induction, generally considered protective effects, were higher in the more severely injured HCV transgenic animals compared with the resistant mice.
Likewise, there appears to be a higher degree of autophagy activation in the animals with higher injury. These findings would suggest that these responses are consequences of the variation in injury rather than the cause of it. Furthermore, mitochondrial AIF release and nuclear DNA damage are consequences of the mitochondrial oxidant stress and dysfunction (Cover et al. 2005 ). This would suggest that the most upstream event that controls most other downstream effects and is significantly different is the mitochondrial oxidant stress. For animals with aggravated injury, this means that the HCV core protein enhances the susceptibility of the mitochondria to a secondary insult.
However, in the resistant animals, it suggested that a part of the transgenic animals developed an adaptation, which made it more difficult to trigger a mitochondrial oxidant stress with APAP overdose. Analysis of mRNA and enzyme activity indicated that glutathione S-transferase mu-3 (GSTm3) was significantly induced in these animals compared with wild-type animals. GSTm3 can catalyze conjugation of electrophiles, e.g., NAPQI, with GSH (Hayes and Pulford 1995) and could thus be protective by attenuating the upstream effects of the injury process (Hayes and McLellan 1999) . It has also been shown that mouse GSTm 1-1 physically interacts with apoptosis signal-regulating kinase 1 (ASK1) and functions as an endogenous inhibitor of ASK1 inside cells, repressing ASK1-mediated signals (Cho et al. 2001) . Since APAP-induced activation of ASK1 (Nakagawa et al. 2008 ) and c-jun N-terminal kinase (JNK), and amplification of the mitochondrial oxidant stress by mitochondrial JNK translocation (Hanawa et al. 2008; Saito et al. 2010a ) play an important role in the cascade of APAP hepatotoxicity, this could be an additional mechanism for protection in these mice.
In summary, chronic overexpression of HCV core protein leads to increased susceptibility to APAP-induced liver injury in some animals by enhanced mitochondrial oxidant stress and amplification of downstream events. However, an as yet undefined chronic stress response appears to trigger an adaptation mechanism, which is responsible for the lower susceptibility of some of the animals. Although there may be multiple protective mechanisms, activation of GSTs is likely an important component. Thus, our data reproduced in an animal model the epidemiological studies showing the increased susceptibility to APAP-induced liver injury in HCV-infected patients and also demonstrated that the chronic stress by HCV core protein overexpression can lead to cellular adaptations rendering the animals more resistant to APAP overdose. A better understanding of the nature of the protection response and what differentiates the exacerbation and protection groups could lead to new ways to treat patients with oxidant-related liver diseases.
